RR

Rob Readnour

Managing Director at Mountain Group Partners

Nashville, Tennessee

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Analytical Chemistry
Chemistry
FDA
Lifesciences
Product Development
Regulatory Affairs
Pharmaceutical Industry
Drug Development
Commercialization
GMP
Veterinary Medicine
Leadership
Drug Discovery
Immunology
Technology Transfer
Validation
Biotechnology
Management
R&D
Vaccines

Education

Lists including Rob

AT
AS
AT
AH

All Series A Investors

14752 people

Investments

Verility

Series A

Total Funding: $4M

TARGAN

Series A

Total Funding: $50M

Advanced Animal Diagnostics

Series E

Total Funding: $7M

AN2 Therapeutics

Series A

Total Funding: $12M

Work Experience

MG
Mountain Group Partners

2018

  • Managing Director

    2018

AA
Advanced Animal Diagnostics

2021

  • Director

    2021

TI
TARGAN Inc.

2019

  • Director

    2019

E
Elanco

2017 - 2018

  • Senior Advisor and Chief Scientific Officer - Elanco Alternative Innovation

    2017 - 2018

EA
Elanco Animal Health

1990 - 2017

  • Senior Director of Product Development, Elanco Animal Health

    1990 - 2017

    Dr. Readnour has led a transformation of Research and Development through the piloting of new approaches to developing animal health drugs, vaccines, enzymes, and diagnostics through virtual product development networks, novel team structures, and alternative funding mechanisms.